» Articles » PMID: 34222726

B Cells in Atherosclerosis: Mechanisms and Potential Clinical Applications

Overview
Date 2021 Jul 5
PMID 34222726
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Because atherosclerotic cardiovascular disease is a leading cause of death worldwide, understanding inflammatory processes underpinning its pathology is critical. B cells have been implicated as a key immune cell type in regulating atherosclerosis. B-cell effects, mediated by antibodies and cytokines, are subset specific. In this review, we focus on elaborating mechanisms underlying subtype-specific roles of B cells in atherosclerosis and discuss available human data implicating B cells in atherosclerosis. We further discuss potential B cell-linked therapeutic approaches, including immunization and B cell-targeted biologics. Given recent evidence strongly supporting a role for B cells in human atherosclerosis and the expansion of immunomodulatory agents that affect B-cell biology in clinical use and clinical trials for other disorders, it is important that the cardiovascular field be cognizant of potential beneficial or untoward effects of modulating B-cell activity on atherosclerosis.

Citing Articles

Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.

Giakomidi D, Ishola A, Nus M Front Cardiovasc Med. 2025; 12:1502124.

PMID: 39957996 PMC: 11825770. DOI: 10.3389/fcvm.2025.1502124.


Lysosome Functions in Atherosclerosis: A Potential Therapeutic Target.

Wang Z, Li X, Moura A, Hu J, Wang Y, Zhang Y Cells. 2025; 14(3).

PMID: 39936975 PMC: 11816498. DOI: 10.3390/cells14030183.


Encompassing view of spatial and single-cell RNA sequencing renews the role of the microvasculature in human atherosclerosis.

Bleckwehl T, Babler A, Tebens M, Maryam S, Nyberg M, Bosteen M Nat Cardiovasc Res. 2024; 4(1):26-44.

PMID: 39715784 DOI: 10.1038/s44161-024-00582-1.


Identification of key genes in gout and atherosclerosis and construction of molecular regulatory networks.

Qing G, Yuan Z Front Cardiovasc Med. 2024; 11:1471633.

PMID: 39677038 PMC: 11638179. DOI: 10.3389/fcvm.2024.1471633.


The role of immunoglobins in atherosclerosis development; friends or foe?.

Zhang L, Li P, Li Y, Qu W, Shi Y, Zhang T Mol Cell Biochem. 2024; .

PMID: 39592554 DOI: 10.1007/s11010-024-05158-y.


References
1.
Yanaba K, Bouaziz J, Haas K, Poe J, Fujimoto M, Tedder T . A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008; 28(5):639-50. DOI: 10.1016/j.immuni.2008.03.017. View

2.
Doran A, Lipinski M, Oldham S, Garmey J, Campbell K, Skaflen M . B-cell aortic homing and atheroprotection depend on Id3. Circ Res. 2011; 110(1):e1-12. PMC: 3253259. DOI: 10.1161/CIRCRESAHA.111.256438. View

3.
Smith D, IRVING S, Sheldon J, Cole D, Kaski J . Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001; 104(7):746-9. DOI: 10.1161/hc3201.094973. View

4.
Meeuwsen J, van Duijvenvoorde A, Gohar A, Kozma M, van de Weg S, Gijsberts C . High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease. J Am Heart Assoc. 2017; 6(9). PMC: 5634255. DOI: 10.1161/JAHA.117.005747. View

5.
Lamontagne F, Garant M, Carvalho J, Lanthier L, Smieja M, Pilon D . Pneumococcal vaccination and risk of myocardial infarction. CMAJ. 2008; 179(8):773-7. PMC: 2553874. DOI: 10.1503/cmaj.070221. View